1. MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma. (March 2023) Authors: Galvani, G.; Leoni, I.; Bergamini, C.; Rizzardi, N.; Melli, M.; Coada, C.A.; Monti, E.; Giovannini, C.; Liparulo, I.; Ferracin, M.; Ravaioli, M.; Cescon, M.; Vasuri, F.; Piscaglia, F.; Negrini, M.; Stefanelli, C.; Fato, R.; Gramantieri, L.; Fornari, F. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗